News Article
18 July 2017
Dr James Cantley wins £40K from the Wellcome Trust ISSF translational award

Dr James Cantley, a graduate of the Oxford Biodesign Short Programme 2015-16, recently secured £40K of funding from the Wellcome Trust ISSF translational award to run a clinical study with his GaitThaw device.

GaitThaw is a wearable device that delivers localized cues to prevent “gait freeze”, a common feature of Parkinson’s disease that reduces quality of life by impairing the ability to walk spontaneously and continuously.

Dr Cantley was previously one of 22 finalists in the EIT Health Headstart/Proof-of-Concept Awards in Dublin in September 2016. He and his team were awarded a grant of €50 000 to help them turn their brilliant idea into a commercially viable business.

 

Programme

  1. Our Mission
  2. Outline of Training Programme
  3. Identify
  4. Invent
  5. Incubate
  6. Short Programme
  7. Resources

People

  1. Directors
  2. Fellows
  3. Steering Committee

Partners

  1. Contributors
  2. Supporters

Achievements

  1. Achievements

News & Events

  1. Events & Workshops

Contact

News Article
18 July 2017
Dr James Cantley wins £40K from the Wellcome Trust ISSF translational award

Dr James Cantley, a graduate of the Oxford Biodesign Short Programme 2015-16, recently secured £40K of funding from the Wellcome Trust ISSF translational award to run a clinical study with his GaitThaw device.

GaitThaw is a wearable device that delivers localized cues to prevent “gait freeze”, a common feature of Parkinson’s disease that reduces quality of life by impairing the ability to walk spontaneously and continuously.

Dr Cantley was previously one of 22 finalists in the EIT Health Headstart/Proof-of-Concept Awards in Dublin in September 2016. He and his team were awarded a grant of €50 000 to help them turn their brilliant idea into a commercially viable business.